The DOI matches its Crossref record; 238 of the 238 references it cites were found in a registry or an index.
Asymmetric organocatalysis: an enabling technology for medicinal chemistry
Abstract
This review provides a comprehensive overview of the recent applications of organocatalytic strategies in pharmaceutical synthesis, with a focus on the preparation of antiviral, anticancer, neuroprotective, cardiovascular, antibacterial and antiparasitic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A new and rapid colorimetric determination of acetylcholinesterase activity
Ellman, G. L., Courtney, K. D., Andres, V., & Featherstone, R. M. (1961) · Biochemical Pharmacology · doi:10.1016/0006-2952(61)90145-9 · Cited by 27,126
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Herbst, R. S., Soria, J.-C., Kowanetz, M., Fine, G. D., Hamid, O., Gordon, M. S., Sosman, J. A., McDermott, D. F., Powderly, J. D., Gettinger, S. N., et al. (2014) · Nature · doi:10.1038/nature14011 · Cited by 5,231
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
An overview of N-heterocyclic carbenes
Hopkinson, M. N., Richter, C., Schedler, M., & Glorius, F. (2014) · Nature · doi:10.1038/nature13384 · Cited by 4,264
Synthetic Organic Electrochemical Methods Since 2000: On the Verge of a Renaissance
Yan, M., Kawamata, Y., & Baran, P. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00397 · Cited by 3,839
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
Iuliano, A. D., Roguski, K. M., Chang, H. H., Muscatello, D. J., Palekar, R., Tempia, S., Cohen, C., Gran, J. M., Schanzer, D., Cowling, B. J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33293-2 · Cited by 3,019
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Drug Discovery: A Historical Perspective
Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,760
Engineering the third wave of biocatalysis
Bornscheuer, U. T., Huisman, G. W., Kazlauskas, R. J., Lutz, S., Moore, J. C., & Robins, K. (2012) · Nature · doi:10.1038/nature11117 · Cited by 2,628
The evolving role of natural products in drug discovery
Koehn, F. E., & Carter, G. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1657 · Cited by 2,572
Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery
Schreiber, S. L. (2000) · Science · doi:10.1126/science.287.5460.1964 · Cited by 2,568
Edmondson, R., Broglie, J. J., Adcock, A. F., & Yang, L. (2014) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2014.573 · Cited by 2,515
CD1d-Restricted and TCR-Mediated Activation of V α 14 NKT Cells by Glycosylceramides
Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., et al. (1997) · Science · doi:10.1126/science.278.5343.1626 · Cited by 2,400
Antibacterial drug discovery in the resistance era
Brown, E. D., & Wright, G. D. (2016) · Nature · doi:10.1038/nature17042 · Cited by 2,247
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
Parmar, D., Sugiono, E., Raja, S., & Rueping, M. (2014) · Chemical Reviews · doi:10.1021/cr5001496 · Cited by 2,118
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061
Organocatalytic Reactions Enabled by N-Heterocyclic Carbenes
Flanigan, D. M., Romanov-Michailidis, F., White, N. A., & Rovis, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00060 · Cited by 2,045
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Rational design of potent sialidase-based inhibitors of influenza virus replication
von Itzstein, M., Wu, W.-Y., Kok, G. B., Pegg, M. S., Dyason, J. C., Jin, B., Van Phan, T., Smythe, M. L., White, H. F., Oliver, S. W., et al. (1993) · Nature · doi:10.1038/363418a0 · Cited by 1,862
Polymeric Graphitic Carbon Nitride for Heterogeneous Photocatalysis
Wang, X., Blechert, S., & Antonietti, M. (2012) · ACS Catalysis · doi:10.1021/cs300240x · Cited by 1,825
mTOR is a key modulator of ageing and age-related disease
Johnson, S. C., Rabinovitch, P. S., & Kaeberlein, M. (2013) · Nature · doi:10.1038/nature11861 · Cited by 1,676
Organocatalytic cascade reactions as a new tool in total synthesis
Grondal, C., Jeanty, M., & Enders, D. (2010) · Nature Chemistry · doi:10.1038/nchem.539 · Cited by 1,582
Privileged scaffolds for library design and drug discovery
Welsch, M. E., Snyder, S. A., & Stockwell, B. R. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.02.018 · Cited by 1,509
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
Organic synthesis provides opportunities to transform drug discovery
Blakemore, D. C., Castro, L., Churcher, I., Rees, D. C., Thomas, A. W., Wilson, D. M., & Wood, A. (2018) · Nature Chemistry · doi:10.1038/s41557-018-0021-z · Cited by 1,485
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
New and emerging HDAC inhibitors for cancer treatment
West, A. C., & Johnstone, R. W. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69738 · Cited by 1,404
Organocatalytic umpolung: N-heterocyclic carbenes and beyond
Bugaut, X., & Glorius, F. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15333e · Cited by 1,394
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
Mice lacking melanin-concentrating hormone are hypophagic and lean
Shimada, M., Tritos, N. A., Lowell, B. B., Flier, J. S., & Maratos-Flier, E. (1998) · Nature · doi:10.1038/25341 · Cited by 1,151
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
Scott, D. E., Bayly, A. R., Abell, C., & Skidmore, J. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.29 · Cited by 1,137
Current and emerging azole antifungal agents
Sheehan, D. J., Hitchcock, C. A., & Sibley, C. M. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.40 · Cited by 1,137
Treating cancer with selective CDK4/6 inhibitors
O'Leary, B., Finn, R. S., & Turner, N. C. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.26 · Cited by 1,137
Guo, H., Fan, Y. C., Sun, Z., Wu, Y., & Kwon, O. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00081 · Cited by 1,133
Target identification and mechanism of action in chemical biology and drug discovery
Schenone, M., Dančík, V., Wagner, B. K., & Clemons, P. A. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1199 · Cited by 1,096
Bowery, N. G., Hill, D. R., Hudson, A. L., Doble, A., Middlemiss, D. N., Shaw, J., & Turnbull, M. (1980) · Nature · doi:10.1038/283092a0 · Cited by 1,096
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
Barth, R. F., Coderre, J. A., Vicente, M. G. H., & Blue, T. E. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0035 · Cited by 1,046
Twenty years on: the impact of fragments on drug discovery
Erlanson, D. A., Fesik, S. W., Hubbard, R. E., Jahnke, W., & Jhoti, H. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.109 · Cited by 1,000
Tron, G. C., Pirali, T., Billington, R. A., Canonico, P. L., Sorba, G., & Genazzani, A. A. (2008) · Medicinal Research Reviews · doi:10.1002/med.20107 · Cited by 996
N‐Heterocyclic Carbene Catalyzed Domino Reactions
Grossmann, A., & Enders, D. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201105415 · Cited by 987
Schneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910
Yu, J., Shi, F., & Gong, L.-Z. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000343 · Cited by 903
2,5-Diketopiperazines: Synthesis, Reactions, Medicinal Chemistry, and Bioactive Natural Products
Borthwick, A. D. (2012) · Chemical Reviews · doi:10.1021/cr200398y · Cited by 880
Acyl anion free N-heterocyclic carbene organocatalysis
Ryan, S. J., Candish, L., & Lupton, D. W. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35522e · Cited by 827
Large-Scale Applications of Amide Coupling Reagents for the Synthesis of Pharmaceuticals
Dunetz, J. R., Magano, J., & Weisenburger, G. A. (2016) · Organic Process Research & Development · doi:10.1021/op500305s · Cited by 819
The rise of fragment-based drug discovery
Murray, C. W., & Rees, D. C. (2009) · Nature Chemistry · doi:10.1038/nchem.217 · Cited by 791
Epidemiology of nosocomial fungal infections
Fridkin, S. K., & Jarvis, W. R. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.499 · Cited by 782
Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol
Brousseau, M. E., Schaefer, E. J., Wolfe, M. L., Bloedon, L. T., Digenio, A. G., Clark, R. W., Mancuso, J. P., & Rader, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031766 · Cited by 774
Role of computer-aided drug design in modern drug discovery
Macalino, S. J. Y., Gosu, V., Hong, S., & Choi, S. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0640-5 · Cited by 762
Patnaik, A., Rosen, L. S., Tolaney, S. M., Tolcher, A. W., Goldman, J. W., Gandhi, L., Papadopoulos, K. P., Beeram, M., Rasco, D. W., Hilton, J. F., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0095 · Cited by 743
Opportunities and challenges in synthetic oligosaccharide and glycoconjugate research
Boltje, T. J., Buskas, T., & Boons, G.-J. (2009) · Nature Chemistry · doi:10.1038/nchem.399 · Cited by 740
Wei, Y., & Shi, M. J. (2013) · Chemical Reviews · doi:10.1021/cr300192h · Cited by 729
Structure of the Protease Domain of Memapsin 2 (β-Secretase) Complexed with Inhibitor
Hong, L., Koelsch, G., Lin, X., Wu, S., Terzyan, S., Ghosh, A. K., Zhang, X. C., & Tang, J. (2000) · Science · doi:10.1126/science.290.5489.150 · Cited by 711
Ahrén, B., Landin-Olsson, M., Jansson, P.-A., Svensson, M., Holmes, D., & Schweizer, A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031907 · Cited by 710
Ding, K., Lu, Y., Nikolovska-Coleska, Z., Wang, G., Qiu, S., Shangary, S., Gao, W., Qin, D., Stuckey, J., Krajewski, K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051122a · Cited by 702
Söderberg-Nauclér, C., Fish, K. N., & Nelson, J. A. (1997) · Cell · doi:10.1016/s0092-8674(01)80014-3 · Cited by 693
Virtual Screening Strategies in Drug Discovery: A Critical Review
Lavecchia, A., & Giovanni, C. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990001 · Cited by 686
Expanding the medicinal chemistry synthetic toolbox
Boström, J., Brown, D. G., Young, R. J., & Keserü, G. M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.116 · Cited by 665
Structure-based design of potent non-peptide MDM2 inhibitors
Ding, K., Lu, Y., Nikolovska-Coleska, Z., Qiu, S., Ding, Y., Gao, W., Stuckey, J., Krajewski, K., Roller, P. P., Tomita, Y., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051147z · Cited by 657
Strategies in the design of antiviral drugs
De Clercq, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd703 · Cited by 652
Efficient Drug Lead Discovery and Optimization
Jorgensen, W. L. (2009) · Accounts of Chemical Research · doi:10.1021/ar800236t · Cited by 649
Recent Developments in Fragment-Based Drug Discovery
Congreve, M., Chessari, G., Tisi, D., & Woodhead, A. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8000373 · Cited by 611
Structure-Activity Relationship of .alpha.-Galactosylceramides against B16-Bearing Mice
Morita, M., Motoki, K., Akimoto, K., Natori, T., Sakai, T., Sawa, E., Yamaji, K., Koezuka, Y., Kobayashi, E., & Fukushima, H. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00012a018 · Cited by 599
Wang, J., Liu, X., & Feng, X. (2011) · Chemical Reviews · doi:10.1021/cr200057t · Cited by 596
Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Development
Ding, Q., Zhang, Z., Liu, J.-J., Jiang, N., Zhang, J., Ross, T. M., Chu, X.-J., Bartkovitz, D., Podlaski, F., Janson, C., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400487c · Cited by 595
The role of p53 in cancer drug resistance and targeted chemotherapy
Hientz, K., Mohr, A., Bhakta-Guha, D., & Efferth, T. (2017) · Oncotarget · doi:10.18632/oncotarget.13475 · Cited by 587
Organocatalysed asymmetric Mannich reactions
Verkade, J. M. M., van Hemert, L. J. C., Quaedflieg, P. J. L. M., & Rutjes, F. P. J. T. (2007) · Chemical Society Reviews · doi:10.1039/b713885g · Cited by 581
Chiral Brønsted acids in enantioselective carbonyl activations – activation modes and applications
Rueping, M., Kuenkel, A., & Atodiresei, I. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15087a · Cited by 546
Organocatalytic Asymmetric Epoxidation and Aziridination of Olefins and Their Synthetic Applications
Zhu, Y., Wang, Q., Cornwall, R. G., & Shi, Y. (2014) · Chemical Reviews · doi:10.1021/cr500064w · Cited by 512
Borowsky, B., Durkin, M. M., Ogozalek, K., Marzabadi, M. R., DeLeon, J., Heurich, R., Lichtblau, H., Shaposhnik, Z., Daniewska, I., Blackburn, T. P., et al. (2002) · Nature Medicine · doi:10.1038/nm741 · Cited by 506
Asymmetric Electrophilic Fluorination Using an Anionic Chiral Phase-Transfer Catalyst
Rauniyar, V., Lackner, A. D., Hamilton, G. L., & Toste, F. D. (2011) · Science · doi:10.1126/science.1213918 · Cited by 503
Afewerki, S., & Córdova, A. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00226 · Cited by 477
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors
Goel, S., Wang, Q., Watt, A. C., Tolaney, S. M., Dillon, D. A., Li, W., Ramm, S., Palmer, A. C., Yuzugullu, H., Varadan, V., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.02.006 · Cited by 470
Zhao, Y., Aguilar, A., Bernard, D., & Wang, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501092z · Cited by 462
The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery
Wright, P. M., Seiple, I. B., & Myers, A. G. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201310843 · Cited by 426
Mondal, S., Yetra, S. R., Mukherjee, S., & Biju, A. T. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.8b00550 · Cited by 405
Applications of asymmetric organocatalysis in medicinal chemistry
Alemán, J., & Cabrera, S. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35380f · Cited by 399
Chiral phosphoric acid-catalyzed asymmetric dearomatization reactions
Xia, Z.-L., Xu-Xu, Q.-F., Zheng, C., & You, S.-L. (2020) · Chemical Society Reviews · doi:10.1039/c8cs00436f · Cited by 398
Lead‐Oriented Synthesis: A New Opportunity for Synthetic Chemistry
Nadin, A., Hattotuwagama, C., & Churcher, I. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201105840 · Cited by 390
Enzymatic functionalization of carbon–hydrogen bonds
Lewis, J. C., Coelho, P. S., & Arnold, F. H. (2011) · Chem. Soc. Rev. · doi:10.1039/c0cs00067a · Cited by 386
Biophysics in drug discovery: impact, challenges and opportunities
Renaud, J.-P., Chung, C.-W., Danielson, U. H., Egner, U., Hennig, M., Hubbard, R. E., & Nar, H. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.123 · Cited by 382
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
Saini, K. S., Loi, S., de Azambuja, E., Metzger-Filho, O., Saini, M. L., Ignatiadis, M., Dancey, J. E., & Piccart-Gebhart, M. J. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.03.009 · Cited by 374
Critical analysis of antibacterial agents in clinical development
Theuretzbacher, U., Bush, K., Harbarth, S., Paul, M., Rex, J. H., Tacconelli, E., & Thwaites, G. E. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0340-0 · Cited by 373
Antivirals and antiviral strategies
Clercq, E. D. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro975 · Cited by 370
Noble, A., & Anderson, J. C. (2013) · Chemical Reviews · doi:10.1021/cr300272t · Cited by 369
KRN7000, a novel immunomodulator, and its antitumor activities.
Kobayashi, E., Motoki, K., Uchida, T., Fukushima, H., & Koezuka, Y. (1995) · PubMed · Cited by 361
Cytomegalovirus: pathogen, paradigm, and puzzle
Boeckh, M., & Geballe, A. P. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45449 · Cited by 357
Fang, X., & Wang, C.-J. (2015) · Chemical Communications · doi:10.1039/c4cc07909d · Cited by 357
Activation of RalA is critical for Ras-induced tumorigenesis of human cells
Lim, K.-H., Baines, A. T., Fiordalisi, J. J., Shipitsin, M., Feig, L. A., Cox, A. D., Der, C. J., & Counter, C. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.030 · Cited by 355
Asymmetric Catalytic Cascade Reactions for Constructing Diverse Scaffolds and Complex Molecules
Wang, Y., Lu, H., & Xu, P.-F. (2015) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5b00217 · Cited by 329
Targeting apoptosis pathways in cancer by Chinese medicine
Li-Weber, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2010.07.015 · Cited by 318
Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
Dallavalle, S., Dobričić, V., Lazzarato, L., Gazzano, E., Machuqueiro, M., Pajeva, I., Tsakovska, I., Zidar, N., & Fruttero, R. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100682 · Cited by 318
Antimalarial drug discovery — approaches and progress towards new medicines
Flannery, E. L., Chatterjee, A. K., & Winzeler, E. A. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3138 · Cited by 313
Corbett, J. W., Ko, S. S., Rodgers, J. D., Gearhart, L. A., Magnus, N. A., Bacheler, L. T., Diamond, S., Jeffrey, S., Klabe, R. M., Cordova, B. C., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990580e · Cited by 305
International Review of Cytology
(1979) · International Review of Cytology · doi:10.1016/s0074-7696(08)60606-3 · Cited by 297
History of antimicrobial drug discovery: Major classes and health impact
Aminov, R. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.10.001 · Cited by 296
Chen, X., Liu, Q., Chauhan, P., & Enders, D. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201709684 · Cited by 293
Dipeptidyl Peptidase IV Inhibitors for the Treatment of Diabetes
Weber, A. E. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030628v · Cited by 278
Strategies to diversify natural products for drug discovery
Li, G., & Lou, H. (2018) · Medicinal Research Reviews · doi:10.1002/med.21474 · Cited by 278
Advances in asymmetric organocatalysis over the last 10 years
Xiang, S.-H., & Tan, B. (2020) · Nature Communications · doi:10.1038/s41467-020-17580-z · Cited by 273
Huffman, M. A., Yasuda, N., DeCamp, A. E., & Grabowski, E. J. J. (1995) · The Journal of Organic Chemistry · doi:10.1021/jo00111a016 · Cited by 260
Agelasphins, novel α-galactosylceramides from the marine sponge Agelas mauritianus
Natori, T., Koezuka, Y., & Higa, T. (1993) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)73889-5 · Cited by 253
Larotrectinib: First Global Approval
Scott, L. J. (2019) · Drugs · doi:10.1007/s40265-018-1044-x · Cited by 237
Annual Reports in Medicinal Chemistry, 1965.
Burger, A. (1967) · Journal of Medicinal Chemistry · doi:10.1021/jm00316a057 · Cited by 235
Promise and challenges in drug discovery and development of hybrid anticancer drugs
Gediya, L. K., & Njar, V. C. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903341705 · Cited by 222
Practical Asymmetric Synthesis of Efavirenz (DMP 266), an HIV-1 Reverse Transcriptase Inhibitor
Pierce, M. E., Parsons, R. L., Radesca, L. A., Lo, Y. S., Silverman, S., Moore, J. R., Islam, Q., Choudhury, A., Fortunak, J. M. D., Nguyen, D., et al. (1998) · The Journal of Organic Chemistry · doi:10.1021/jo981170l · Cited by 218
Structure−Activity Relationships of Pregabalin and Analogues That Target the α2-δ Protein
Belliotti, T. R., Capiris, T., Ekhato, I. V., Kinsora, J. J., Field, M. J., Heffner, T. G., Meltzer, L. T., Schwarz, J. B., Taylor, C. P., Thorpe, A. J., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049762l · Cited by 212
Grüninger-Leitch, F., Schlatter, D., Küng, E., Nelböck, P., & Döbeli, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109266200 · Cited by 211
Organocatalysis in aqueous media
van der Helm, M. P., Klemm, B., & Eelkema, R. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0116-0 · Cited by 206
Thornberry, N., & Weber, A. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780091028 · Cited by 202
Pushing the Limits with Squaramide-Based Organocatalysts in Cyclic Carbonate Synthesis
Sopeña, S., Martin, E., Escudero-Adán, E. C., & Kleij, A. W. (2017) · ACS Catalysis · doi:10.1021/acscatal.7b00475 · Cited by 195
Targeting oncogenic Raf protein-serine/threonine kinases in human cancers
Roskoski, R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.013 · Cited by 194
The history of antiretrovirals: key discoveries over the past 25 years
De Clercq, E. (2009) · Reviews in Medical Virology · doi:10.1002/rmv.624 · Cited by 184
Potent and orally active small-molecule inhibitors of the MDM2-p53 interaction
Yu, S., Qin, D., Shangary, S., Chen, J., Wang, G., Ding, K., McEachern, D., Qiu, S., Nikolovska-Coleska, Z., Miller, R., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901400z · Cited by 180
Direct Asymmetric Amination of α-Branched Cyclic Ketones Catalyzed by a Chiral Phosphoric Acid
Yang, X., & Toste, F. D. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b00229 · Cited by 179
Current landscape in the discovery of novel antibacterial agents
Vila, J., Moreno-Morales, J., & Ballesté-Delpierre, C. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.09.015 · Cited by 173
Towards the overcoming of anticancer drug resistance mediated by p53 mutations
Cao, X., Hou, J., An, Q., Assaraf, Y. G., & Wang, X. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100671 · Cited by 172
The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder
Woelfer, M., Kasties, V., Kahlfuss, S., & Walter, M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.03.034 · Cited by 171
Lin, Q., Meloni, D., Pan, Y., Xia, M., Rodgers, J., Shepard, S., Li, M., Galya, L., Metcalf, B., Yue, T.-Y., et al. (2009) · Organic Letters · doi:10.1021/ol900350k · Cited by 171
Wright, A. D., König, G. M., Angerhofer, C. K., Greenidge, P., Linden, A., & Desqueyroux-Faúndez, R. (1996) · Journal of Natural Products · doi:10.1021/np9602325 · Cited by 165
Prevalence of Diarylprolinol Silyl Ethers as Catalysts in Total Synthesis and Patents
Reyes-Rodríguez, G. J., Rezayee, N. M., Vidal-Albalat, A., & Jørgensen, K. A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00583 · Cited by 163
Two decades of new drug development for central nervous system disorders
Kesselheim, A. S., Hwang, T. J., & Franklin, J. M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4793 · Cited by 160
Zampanolide, a new cytotoxic marcrolide from a marine sponge
Tanaka, J., & Higa, T. (1996) · Tetrahedron Letters · doi:10.1016/0040-4039(96)01149-5 · Cited by 154
Gumy, L. F., Bampton, E. T. W., & Tolkovsky, A. M. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.10.004 · Cited by 150
Ishikawa, H., Suzuki, T., Orita, H., Uchimaru, T., & Hayashi, Y. (2010) · Chemistry - A European Journal · doi:10.1002/chem.201001108 · Cited by 148
Stereocontrolled organocatalytic synthesis of prostaglandin PGF2α in seven steps
Coulthard, G., Erb, W., & Aggarwal, V. K. (2012) · Nature · doi:10.1038/nature11411 · Cited by 148
Single‐Electron Transfer Reactions Enabled by N‐Heterocyclic Carbene Organocatalysis
Li, Q., Zeng, R., Han, B., & Li, J. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202004059 · Cited by 148
Self-citationLepesheva, G. I., Hargrove, T. Y., Anderson, S. M., Kleshchenko, Y. Y., Furtak, V. A., Wawrzak, Z., Villalta, F., & Waterman, M. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133215 · Cited by 146
Brønsted acid-catalysed enantioselective construction of axially chiral arylquinazolinones
Wang, Y., Zheng, S., Hu, Y., & Tan, B. (2017) · Nature Communications · doi:10.1038/ncomms15489 · Cited by 146
Lepesheva, G. I., Ott, R. D., Hargrove, T. Y., Kleshchenko, Y. Y., Schuster, I., Nes, W. D., Hill, G. C., Villalta, F., & Waterman, M. R. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.10.011 · Cited by 140
Liu, Y., Wang, X., Wang, G., Yang, Y., Yuan, Y., & Ouyang, L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.05.018 · Cited by 135
Self-citationDavis, T. A., & Johnston, J. N. (2011) · Chemical Science · doi:10.1039/c1sc00061f · Cited by 124
A comprehensive review on anticancer mechanisms of the main carotenoid of saffron, crocin
Hoshyar, R., & Mollaei, H. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12776 · Cited by 124
Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review
Sarkar, R., Banerjee, S., Amin, S. A., Adhikari, N., & Jha, T. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112171 · Cited by 121
RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer
Yan, C., & Theodorescu, D. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014415 · Cited by 119
Pot Economy in the Synthesis of Prostaglandin A 1 and E 1 Methyl Esters
Hayashi, Y., & Umemiya, S. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209380 · Cited by 118
Jiang, X., Sun, Y., Yao, J., Cao, Y., Kai, M., He, N., Zhang, X., Wang, Y., & Wang, R. (2012) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201100792 · Cited by 111
Lin, S., Lin, S., Hsu, J.-N., Chang, C., Chien, C., Wang, Y., Wu, H., Jeng, U., Kehn‐Hall, K., & Hou, M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01913 · Cited by 109
Chen, H., Liao, H., Liu, Y., Zheng, Y., Wu, X., Su, Z., Zhang, X., Lai, Z., Lai, X., Lin, Z., et al. (2014) · Fitoterapia · doi:10.1016/j.fitote.2014.11.017 · Cited by 106
Self-citationMiyaoka, H., Shimomura, M., Kimura, H., Yamada, Y., Kim, H., & Yusuke, W. (1998) · Tetrahedron · doi:10.1016/s0040-4020(98)00818-7 · Cited by 106
Vom Razemat zum Eutomer: (S)-Ketamin
Adams, H. A., & Werner, C. (1997) · Der Anaesthesist · doi:10.1007/s001010050503 · Cited by 104
The development of MOFs-based nanomaterials in heterogeneous organocatalysis
Liu, X., Tang, B., Long, J., et al. (2018) · 中国科学通报:英文版 · doi:10.1016/j.scib.2018.03.009 · Cited by 101
TenBrink, R. E., Bergh, C. L., Duncan, J. N., Harris, D. W., Huff, R. M., Lahti, R. A., Lawson, C., Lutzke, B. S., Martin, I. J., Rees, S. A., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960084f · Cited by 99
US Food and Drug Administration approval of esketamine and brexanolone
Cristea, I. A., & Naudet, F. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30292-5 · Cited by 98
Wang, S., Jiang, Y., Wu, S., Dong, G., Miao, Z., Zhang, W., & Sheng, C. (2016) · Organic Letters · doi:10.1021/acs.orglett.6b00155 · Cited by 95
Brügger‐Verdon, V., Duman, M., Bochud, M., Münger, E., Heller, M., Ruff, S., & Jacob, C. (2017) · Nature Communications · doi:10.1038/ncomms14272 · Cited by 92
Yang, M.-C., Peng, C. Y., Huang, H., Yang, L., He, X., Huang, W., Cui, H., He, G., & Han, B. (2017) · Organic Letters · doi:10.1021/acs.orglett.7b03516 · Cited by 92
Self-citationAbbasov, M. E., & Romo, D. (2014) · Natural Product Reports · doi:10.1039/c4np00025k · Cited by 90
Zhou, R., Wu, Q., Guo, M., Huang, W., He, X., Yang, L., Peng, F., He, G., & Han, B. (2015) · Chemical Communications · doi:10.1039/c5cc04968g · Cited by 88
Self-citationEnantioselective Synthesis of SNAP-7941: Chiral Dihydropyrimidone Inhibitor of MCH1-R
Goss, J. M., & Schaus, S. E. (2008) · The Journal of Organic Chemistry · doi:10.1021/jo801463j · Cited by 85
Medicinal Chemistry Strategies to Disrupt the p53–MDM2/MDMX Interaction
Lemos, A., Leão, M., Soares, J., Palmeira, A., Pinto, M. M. M., Saraiva, L., & Sousa, M. E. (2016) · Medicinal Research Reviews · doi:10.1002/med.21393 · Cited by 85
Ötvös, S. B., Pericàs, M. À., & Kappe, C. O. (2019) · Chemical Science · doi:10.1039/c9sc04752b · Cited by 78
Medicines for the Mind: Policy-Based “Pull” Incentives for Creating Breakthrough CNS Drugs
Choi, D. W., Armitage, R., Brady, L. S., Coetzee, T., Fisher, W. W., Hyman, S. E., Pande, A. C., Paul, S. M., Potter, W. Z., Roin, B. N., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.10.027 · Cited by 77
Wu, S., Li, Y., Xu, G., Chen, S., Zhang, Y., Liu, N., Dong, G., Miao, C., Su, H., Zhang, W., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.039 · Cited by 74
Wang, B., Peng, F., Huang, W., Zhou, J., Zhang, N., Sheng, J., Haruehanroengra, P., He, G., & Han, B. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.013 · Cited by 73
Self-citationCatalytic Enantioselective Flow Processes with Solid‐Supported Chiral Catalysts
Rodríguez‐Escrich, C., & Pericàs, M. À. (2018) · The Chemical Record · doi:10.1002/tcr.201800097 · Cited by 73
Marilines A–C: Novel Phthalimidines from the Sponge‐Derived Fungus Stachylidium sp.
Almeida, C., Hemberger, Y., Stefan, S. M., Bouhired, S. M., Natesan, L., Kehraus, S., DIMAS, K. S., Gütschow, M., Bringmann, G., & König, G. M. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201103278 · Cited by 69
Anti-inflammatory activity of β-patchoulene isolated from patchouli oil in mice
Zhang, Z., Chen, X., Chen, H., Wang, L., Liang, J.-L., Luo, D., Liu, Y., Yang, H., Li, Y., Xie, J., et al. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.04.028 · Cited by 69
Self-citationSynthesis and anti-Influenza virus activity of 7-O-Alkylated derivatives related to zanamivir
Honda, T., Masuda, T., Yoshida, S., Arai, M., Kaneko, S., & Yamashita, M. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00329-3 · Cited by 68
Waeber, B. (2003) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.1.1.43 · Cited by 66
Preparation of (−)-Nutlin-3 Using Enantioselective Organocatalysis at Decagram Scale
Davis, T. A., Vilgelm, A. E., Richmond, A. J., & Johnston, J. N. (2013) · The Journal of Organic Chemistry · doi:10.1021/jo401321a · Cited by 62
Zhao, Q., Peng, C. Y., Huang, H., Liu, S., Zhong, Y., Huang, W., He, G., & Han, B. (2018) · Chemical Communications · doi:10.1039/c8cc04732d · Cited by 61
Self-citationNew isocoumarins and alkaloid from Chinese insect medicine, Eupolyphaga sinensis Walker
Jiang, H.-L., Luo, X.-H., Wang, X.-Z., Yang, J.-L., Yao, X., Crews, P., Valeriote, F. A., & Wu, Q. (2012) · Fitoterapia · doi:10.1016/j.fitote.2012.06.005 · Cited by 60
Dutschman, G. E., Grill, S. P., Gullen, E. A., Haraguchi, K., Takeda, S., Tanaka, H., Baba, M., & Cheng, Y. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1640-1646.2004 · Cited by 60
Xu, F., Corley, E. G., Zacuto, M. J., Conlon, D. A., Pipik, B., Humphrey, G. R., Murry, J. A., & Tschaen, D. M. (2010) · The Journal of Organic Chemistry · doi:10.1021/jo902573q · Cited by 59
Natural Product MDM2 Inhibitors: Anticancer Activity and Mechanisms of Action
Qin, J., Nag, S. A., Voruganti, S., Wang, W., & Zhang, R. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803988910 · Cited by 58
Ortiz, A., Benkovics, T., Beutner, G. L., Shi, Z., Bultman, M. S., Nye, J. A., Sfouggatakis, C., & Kronenthal, D. R. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201502290 · Cited by 57
Zhang, Y., Wang, C., Huang, W., Haruehanroengra, P., Peng, C. Y., Sheng, J., Han, B., & He, G. (2018) · Organic Chemistry Frontiers · doi:10.1039/c8qo00422f · Cited by 57
Self-citationLiu, X., Zhou, G., Gong, Y., Yao, Z., Zuo, X., Zhang, W., & Zhou, Y. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b00139 · Cited by 57
Generation of a Complete, Soluble, and Catalytically Active Sterol 14α-Demethylase−Reductase Complex
Lamb, D. C., Kelly, D. E., Kanamarlapudi, V., Manning, N. J., Bligh, H. F. J., Schunck, W., & Kelly, S. L. (1999) · Biochemistry · doi:10.1021/bi9825089 · Cited by 56
Multisite Organic–Inorganic Hybrid Catalysts for the Direct Sustainable Synthesis of GABAergic Drugs
Leyva‐Pérez, A., García, P. G., & Corma, A. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403049 · Cited by 55
Antitumor effects of traditional Chinese medicine targeting the cellular apoptotic pathway
Lin, X., Xu, H., Zhao, X., Liu, X., Zhang, K., & Xu, P. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s80902 · Cited by 54
Pei, Z., Li, X., von Geldern, T. W., Madar, D. J., Longenecker, K. L., Yong, H., Lubben, T. H., Stewart, K. D., Zinker, B. A., Backes, B. J., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060955d · Cited by 54
Shin, W.-J., & Seong, B. L. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1560261 · Cited by 54
Spotting trends in organocatalysis for the next decade
Lassaletta, J. M. (2020) · Nature Communications · doi:10.1038/s41467-020-17600-y · Cited by 54
Vara, B., Mayasundari, A., Tellis, J. C., Danneman, M. W., Arredondo, V., Davis, T. A., Min, J., Finch, K. E., Guy, R. K., & Johnston, J. N. (2014) · The Journal of Organic Chemistry · doi:10.1021/jo501003r · Cited by 51
Highly Enantioselective Catalytic Synthesis of Neurite Growth-Promoting Secoyohimbanes
Antonchick, A. P., López-Tosco, S., Parga, J. A., Sievers, S., Schürmann, M., Preut, H., Höing, S., Schöler, H. R., Sterneckert, J. L., Rauh, D., et al. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.03.011 · Cited by 48
Butlen‐Ducuing, F., Pétavy, F., Guizzaro, L., Zienowicz, M., Salmonson, T., Haas, M., Corruble, E., & Alteri, E. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.237 · Cited by 48
Mitophagy in cardiovascular disease
Zhou, H., He, L., Xu, G., & Chen, L. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.04.033 · Cited by 48
Yokoyama, R., Matsumoto, S., Nomura, S., et al. (2009) · Tetrahedron · doi:10.1016/j.tet.2009.05.004 · Cited by 46
Synthesis and Potent Antimalarial Activity of Kalihinol B
Daub, M. E., Prudhomme, J. G., Roch, K. G. L., & Vanderwal, C. D. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b01152 · Cited by 46
PD-1/PD-L1 in cardiovascular disease
Sun, Y., Li, L., Wu, Y., & Yang, K. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.02.019 · Cited by 46
Clinical protein science in translational medicine targeting malignant melanoma
Gil, J., Betancourt, L. H., Pla, I., Sanchez, A., Appelqvist, R., Miliotis, T., Kuras, M., Oskolas, H., Kim, Y., Horvath, Z., et al. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09468-6 · Cited by 45
Basso, A. M., Bratcher, N. A., Gallagher, K. B., Cowart, M., Zhao, C., Sun, M., Esbenshade, T. A., Brune, M. E., Fox, G. B., Schmidt, M. U., et al. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.04.043 · Cited by 45
Catalytic Enantioselective Transannular Morita–Baylis–Hillman Reaction
Mato, R., Manzano, R., Reyes, E., Carrillo, L., Uria, U., & Vicario, J. L. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b03679 · Cited by 45
Chen, X., Xiong, F., Chen, W., He, Q., & Chen, F. (2014) · The Journal of Organic Chemistry · doi:10.1021/jo402829b · Cited by 44
Mavrova, A. T., Wesselinova, D. W., Vassilev, N. G., & Tsenov, J. A. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.03.010 · Cited by 42
Kötzner, L., Leutzsch, M., Sievers, S., Patil, S., Waldmann, H., Zheng, Y., Thiel, W., & List, B. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201602932 · Cited by 42
Gong, J., Hendifar, A. E., Tuli, R., Chuang, J., Cho, M. T., Chung, V. M., Li, D., & Salgia, R. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0210-9 · Cited by 41
Difference in Risks of Allergic Reaction to Sulfonamide Drugs Based on Chemical Structure
Verdel, B. M., Souverein, P. C., Egberts, T. C. G., & Leufkens, H. G. M. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g642 · Cited by 40
Pelšs, A., Gandhamsetty, N., Smith, J. R., Mailhol, D., Silvi, M., Watson, A. J. A., Perez-Powell, I., Prévost, S., Schützenmeister, N., Moore, P. R., et al. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201802498 · Cited by 40
Cited by
Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396
Self-citationPeluso, P., & Chankvetadze, B. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00846 · Cited by 371
Luo, M.-L., Zhao, Q., He, X.-H., Xie, X., Zhu, H.-P., You, F.-M., Peng, C., Zhan, G., & Huang, W. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114574 · Cited by 25
Self-citationRetracted
Metadata
- Authors
- Han, B., He, X.-H., Liu, Y.-Q., He, G., Peng, C., & Li, J.-L.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2021
- Volume
- 50
- Issue
- 3
- Pages
- 1522-1586
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W3124681459
- Cited by
- 402
- References
- 238
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.